Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.32 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21008249 | 0.93 | KDM4E (0.34) | KDM4EATML3MBTL1 | |
| SCHEMBL21007543 | 0.85 | KDM4E (0.44) | KDM4EATML3MBTL1HSD17B10PDE1B | |
| SCHEMBL18593800 | 0.85 | ATM (0.41) | KDM4EATML3MBTL1HSD17B10MCL1 | |
| SCHEMBL21007301 | 0.84 | KDM4E (0.40) | KDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL21008226 | 0.82 | KDM4E (0.42) | KDM4EATML3MBTL1HSD17B10MCL1 | |
| SCHEMBL21008240 | 0.82 | GPR3 (0.34) | KDM4EATML3MBTL1 | |
| SCHEMBL21007545 | 0.81 | ATM (0.41) | KDM4EATML3MBTL1HSD17B10MCL1 | |
| SCHEMBL21008106 | 0.81 | KDM4E (0.37) | KDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL21007544 | 0.81 | KDM4E (0.37) | KDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL21007522 | 0.81 | KDM4E (0.37) | KDM4EATML3MBTL1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11349081-B2 | Azaindolocarbazole compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-05-31 | — | — | US | disclosed |
| US-20190148646-A1 | AZAINDOLOCARBAZOLE COMPOUNDS | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2019-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190148646-A1 | AZAINDOLOCARBAZOLE COMPOUNDS | SLC25A21, OXA1L, OCIAD1 | KDM4E 1464/4885ATM 4426/4885L3MBTL1 3880/4885 |
| US-11349081-B2 | Azaindolocarbazole compounds | SLC25A21, OXA1L, OCIAD1 | KDM4E 1464/4885ATM 4426/4885L3MBTL1 3880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.